Influence of Monovalent Cation Concentrations on Monocyte-Mediated ADCC

  • Stephan Ladisch
  • Lisa Ulsh
  • Stephen A. Feig
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 146)


Studies of effector cell biochemical processes associated with cell-mediated cytolysis have been undertaken by numerous laboratories to define the conditions required for the expression of cytolytic activity, and hopefully to ultimately eludicate mechanisms of cytolysis. By such studies, the requirements for the divalent cations, Ca++ and/or Mg++, in T-cell and non-T cell-mediated cytolysis have been demonstrated using chelating agents (1,2). Similar studies of the possible importance of the monovalent cations, Na+ and K+, had been impeded by lack of equally selective means of altering their intracellular concentrations. However, inhibition of cytolytic activity by ouabain (3,4). which specifically blocks membrane active transport of Na+ and K+ (5), indicates that these cations as well may influence cytolytic activity.


Active Transport Effector Cell Potassium Concentration Cation Concentration Monovalent Cation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Golstein, P., and E.T. Smith. The lethal hit stage of mouse T and non-T cell mediated cytolysis: differences in cation requirements and characterization on an analytical “cation pulse” method. Eur. J. Immunol. 6:31 (1976).PubMedCrossRefGoogle Scholar
  2. 2.
    Plaut, M., Bubbers, J.E., and C.S. Henney. Studies on the mechanism of lymphocyte-mediated cytolysis. VII. Two stages in the T cell-mediated lytic cycle with distinct cation requirements. J. Immunol. 116:150 (1976).PubMedGoogle Scholar
  3. 3.
    Lawrence, E.C., Muchmore, A.V., Dooley, N.J. and R.M. Blaese. Differential effects of ouabain on human cell-mediated cytotoxicity. Cell. Immunol. 46:100 (1979).PubMedCrossRefGoogle Scholar
  4. 4.
    Wright, P., and M. De Marchi. Ouabain inhibition of human lymphocyte cytotoxicity. Cell. Immunol. 45:318 (1979).PubMedCrossRefGoogle Scholar
  5. 5.
    Skou, J.C. Enzymatic basis for active transport of Na++ and K+ across cell membrane. Physiol. Rev. 45:596 (1965).PubMedGoogle Scholar
  6. 6.
    Ladisch, S., and S.A. Feig. Submitted, J. Immunol.Google Scholar
  7. 7.
    Ladisch, S., Feig, S.A., Henderso, T., and B. Berman. Submitted, J. Immunol. Meth.Google Scholar
  8. 8.
    Kragballe, K., Beck-Nielsen, W., Pedrsen, O., Ellegaard, J., and N.S. Sorensen. Monocyte-mediated antibody-dependent cytotoxicity. Modulation by glycolysis and insulin. Scand. J. Haematol. 26:137 (1981).PubMedCrossRefGoogle Scholar
  9. 9.
    Poplack, D.G., Bonnard, G.D., Holiman, B.J., and R.M. Blaese. Monocyte-mediated antibody-dependent cellular cytotoxicity. A clinical test of monocyte function. Blood 48:809 (1976).PubMedGoogle Scholar
  10. 10.
    Segel, G.B. and M.A. Lichtman. Potassium transport in human blood lymphocytes treated with phytohemagglutinin. J. Clin. Invest. 58:1358 (1976).PubMedCrossRefGoogle Scholar
  11. 11.
    Kernan, R.P. Cell K. Butterworth, Washington, pp. 121–141 (1965).Google Scholar
  12. 12.
    Koller, C.A., Laufman, H.B., and A.F. Lo Buglio. Characterization of monocyte antibody dependent cellular cytotoxicity (ADCC) against RBC targets. Blod 51:152a (1978).Google Scholar

Copyright information

© Plenum Press, New York 1982

Authors and Affiliations

  • Stephan Ladisch
    • 1
  • Lisa Ulsh
    • 1
  • Stephen A. Feig
    • 1
  1. 1.Division of Hematology/Oncology and Gwynne Hazen Cherny Memorial Laboratories Dept. of PediatricsUCLA School of MedicineLos AngelesUSA

Personalised recommendations